PharmaStem Patents Confirmed after Reexamination by Patent Office
"Considering the pioneering research of our inventors which eventually led to the creation of the private and public cord blood banking industry, I was always confident that the Patent Office would confirm the validity of our patents and I am gratified that all three senior patent examiners involved in the reexamination reached the same conclusion," said Nicholas Didier, CEO and President of PharmaStem. "It is important for our licensees - of which there are over 20 - to know that the patents they have licensed are valid, and can protect them."
Although the majority of private cord blood banks are licensed under PharmaStem's patent portfolio, ViaCord (VIAC), Cryo-Cell (CCEL), CBR Systems and CorCell do not have a license to practice the inventions claimed in PharmaStem's patents.
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.